Clinical Trial Update: A Clinical Pharmacology Study of TS-142 in Patients with Obstructive Sleep Apnea Hypopnea. [Phase 1]

View source ↗

Summary

A Phase 1 clinical pharmacology study of TS-142 in patients with mild obstructive sleep apnea hypopnea has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Sleep Apnea

Drugs mentioned

• TS-142

Snippet

Sponsor: Taisho Pharmaceutical Co., Ltd. | Conditions: Patients with Mild Obstructive Sleep Apnea Hypopnea | Phase 1 | Status: COMPLETED